Dasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
OEM Services
The supplier provides OEM services for popular brands
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (13)
  • Dasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib
  • Dasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib
  • Dasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib
  • Dasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib
  • Dasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib
  • Dasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib
Find Similar Products

Basic Info.

Certification
GMP, ISO 9001, USP, BP
Suitable for
Adult
State
Powder
Purity
>98%
Sample
Available
OEM
Available
MOQ
1kg
Keyword 1
Dasatinib
Keyword 2
Dasatinib Powder
Storage
Dry and Cool Place
Transport Package
Foil Bag/25kg Drum
Specification
98%
Trademark
/
Origin
China
Production Capacity
10000

Product Description

Dasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib

Description
Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body. Dasatinib, previously known as BMS-354825, Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Name Dasatinib
Grade Pharmaceutical Grade
Appearance White powder
Specification 98%


Function and Application
Dasatinib is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other cancer treatments have not been effective.
Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitorapproved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Dasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibDasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibDasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibDasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibDasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibDasatinib Powder CAS 302964-08-5 Antineoplastic Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier